Literature DB >> 27088803

Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells.

Christoph T Berger, Christoph Hess.   

Abstract

Tregs are critical for control of self-reactive T cells that escape thymic selection and end up in the periphery. Treg subsets suppress effector T cell populations through the secretion of immunosuppressive molecules and inhibitory cytokines as well as cell contact-dependent mechanisms. In this issue of the JCI, Wen and colleagues describe another mechanism by which Tregs suppress effector T cell populations. Specifically, the authors reveal that CD8+ T cells in close contact with target T cells release NADPH oxidase 2-containing microvesicles that inhibit TCR activation by elevating ROS and thereby reducing phosphorylation of the TCR-associated kinase ZAP70. Together, the results of this study provide important insight into CD8+ Treg function and into the development of autoimmunity in older individuals.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088803      PMCID: PMC4855932          DOI: 10.1172/JCI87429

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

Authors:  Benjamin Terrier; Guillaume Geri; Wahiba Chaara; Yves Allenbach; Michelle Rosenzwajg; Nathalie Costedoat-Chalumeau; Pierre Fouret; Lucile Musset; Olivier Benveniste; Adrien Six; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheum       Date:  2011-12-06

Review 2.  CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.

Authors:  Gilberto Filaci; Daniela Fenoglio; Francesco Indiveri
Journal:  Autoimmunity       Date:  2010-07-29       Impact factor: 2.815

3.  Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.

Authors:  Maxime Samson; Sylvain Audia; Jennifer Fraszczak; Malika Trad; Paul Ornetti; Daniela Lakomy; Marion Ciudad; Vanessa Leguy; Sabine Berthier; Julien Vinit; Patrick Manckoundia; Jean-Francis Maillefert; Jean-François Besancenot; Serge Aho-Glele; Nils Olivier Olsson; Bernard Lorcerie; Loïc Guillevin; Luc Mouthon; Philippe Saas; Andrew Bateman; Laurent Martin; Nona Janikashvili; Nicolas Larmonier; Bernard Bonnotte
Journal:  Arthritis Rheum       Date:  2012-11

4.  Th17 and Th1 T-cell responses in giant cell arteritis.

Authors:  Jiusheng Deng; Brian R Younge; Richard A Olshen; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

5.  Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.

Authors:  R Horváth; D Rožková; J Lašťovička; A Poloučková; P Sedláček; A Sedivá; R Spíšek
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

6.  NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.

Authors:  Zhenke Wen; Yasuhiro Shimojima; Tsuyoshi Shirai; Yinyin Li; Jihang Ju; Zhen Yang; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 7.  Genetic, biochemical, and clinical features of chronic granulomatous disease.

Authors:  B H Segal; T L Leto; J I Gallin; H L Malech; S M Holland
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

8.  Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells.

Authors:  Kihyun Lee; Hee Yeon Won; Myung Ae Bae; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-18       Impact factor: 11.205

9.  Decreased CD4+CD29+ (memory T) cells in patients with chronic granulomatous disease.

Authors:  M Hasui; K Hattori; S Taniuchi; U Kohdera; A Nishikawa; Y Kinoshita; Y Kobayashi
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

Review 10.  Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells.

Authors:  Troy R Torgerson; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2007-10       Impact factor: 10.793

View more
  5 in total

1.  Regulatory T cell features in chronic granulomatous disease.

Authors:  A van de Geer; E Cuadrado; M C Slot; R van Bruggen; D Amsen; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2019-04-16       Impact factor: 4.330

Review 2.  Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.

Authors:  Cornelia M Weyand; Yi Shen; Jorg J Goronzy
Journal:  Free Radic Biol Med       Date:  2018-03-07       Impact factor: 7.376

Review 3.  The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells.

Authors:  Lin-Lin Ye; Xiao-Shan Wei; Min Zhang; Yi-Ran Niu; Qiong Zhou
Journal:  Front Immunol       Date:  2018-03-22       Impact factor: 7.561

4.  Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients.

Authors:  Marsha Pellegrino; Antonino Crinò; Manuela M Rosado; Alessandra Fierabracci
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

5.  Superagonistic CD28 protects against renal ischemia injury induced fibrosis through a regulatory T-cell expansion dependent mechanism.

Authors:  Yiran Liang; Ning Xue; Xiaoyan Wang; Xiaoqiang Ding; Yi Fang
Journal:  BMC Nephrol       Date:  2019-11-09       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.